Download Sample
Add to CartGlobal Excipients Market Growth, Share, Size, Trends and Forecast (2025 - 2031)
By Product;
Polymers, Alcohols, Sugars, Minerals, and Gelatin.By Function;
Binders and Coating Agents.By Geography;
North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2021 - 2031).Introduction
Global Excipients Market (USD Million), 2021 - 2031
In the year 2023, the Global Excipients Market was valued at USD 6,216.33 million. The size of this market is expected to increase to USD 9,359.41 million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of 6.0%.
The global excipients market continues to witness robust growth, driven by the burgeoning pharmaceutical and biotechnology sectors, alongside the escalating demand for novel drug formulations and delivery systems. Excipients, inert substances added to pharmaceutical formulations to confer specific functionalities, play a pivotal role in drug development, aiding in the stabilization, solubilization, and controlled release of active pharmaceutical ingredients (APIs). As pharmaceutical companies strive to enhance drug efficacy, safety, and patient compliance, the importance of excipients in facilitating the formulation process and optimizing therapeutic outcomes has become increasingly apparent.
Several factors contribute to the sustained expansion of the excipients market. These include the rising prevalence of chronic and infectious diseases, demographic shifts such as aging populations, and the growing demand for generic drugs. Advancements in drug delivery technologies, coupled with increasing investments in research and development, are propelling innovation in excipient formulations. Excipients are also integral to the development of specialized dosage forms, including sustained-release formulations, orally disintegrating tablets, and targeted drug delivery systems, catering to diverse patient needs and therapeutic requirements.
Stringent regulatory standards and quality requirements imposed by regulatory authorities worldwide underscore the significance of excipient selection and characterization in pharmaceutical manufacturing. As such, excipient manufacturers are continually investing in advanced manufacturing processes and analytical techniques to ensure compliance with regulatory guidelines and meet the stringent quality standards expected by pharmaceutical companies.
Global Excipients Market Recent Developments
-
In June 2023, Ashland introduced Polyplasdone Plus, a co-processed multifunctional direct compression superdisintegrant comprising a glidant and lubricant.
-
In October 2023, Lubrizol Life Science Health was awarded the Finished Formulation Award for Apisolex Polymer solubilizing excipient at CPhI Barcelona.
Segment Analysis
The Global Excipients Market has been segmented by Product, Function, and Geography. Excipients are inactive substances formulated alongside the active pharmaceutical ingredient (API) in medicinal products for various purposes, such as aiding in the manufacturing process, improving stability, enhancing solubility, and ensuring proper delivery of the active ingredient to the target site. In terms of products, excipients encompass a wide range of substances including binders, fillers, disintegrants, lubricants, preservatives, and others.
Each excipient serves a specific function in the formulation of pharmaceuticals, contributing to the overall efficacy and safety of the drug product. Moreover, the market segmentation based on function reflects the diverse roles that excipients play in pharmaceutical formulations. Geographically, the market for excipients is spread across regions such as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa, each presenting its unique set of opportunities and challenges. Understanding these segments is crucial for stakeholders in the pharmaceutical industry to strategize effectively and capitalize on emerging trends and opportunities in the global excipients market.
Global Excipients Segment Analysis
In this report, the Global Excipients Market has been segmented by Product, Function and Geography.
Global Excipients Market, Segmentation by Product
The Global Excipients Market has been segmented by Product into Polymers, Alcohols, Sugars, Minerals and Gelatin.
The Excipients Market has witnessed significant growth in recent years and is projected to continue expanding at a substantial rate in the coming years. Excipients play a crucial role in pharmaceutical formulations, serving as inert substances that aid in the manufacturing process, stability, and delivery of active pharmaceutical ingredients (APIs). These substances are essential for ensuring the effectiveness, safety, and quality of pharmaceutical products. The market for excipients has been segmented by product type into polymers, alcohols, sugars, minerals, and gelatin. Polymers, such as cellulose derivatives, polyethylene glycols (PEGs), and acrylic polymers, are widely used in pharmaceutical formulations due to their versatility and compatibility with various APIs. They serve as binders, disintegrants, film-formers, and viscosity enhancers, among other functions.
Alcohols, including ethanol and propylene glycol, are commonly utilized as solvents, preservatives, and co-solvents in pharmaceutical formulations. Sugars such as sucrose, lactose, and mannitol are utilized as fillers, sweetening agents, and stabilizers in oral dosage forms. They also serve as bulking agents in lyophilized formulations. Minerals like calcium carbonate, magnesium stearate, and sodium chloride find applications as lubricants, glidants, and flow enhancers in solid dosage forms. They contribute to improving the manufacturability and functionality of pharmaceutical products. Gelatin, derived from animal sources, is utilized as a gelling agent and capsule material in various dosage forms, including soft gelatin capsules.
The selection of excipients depends on several factors, including the desired dosage form, route of administration, compatibility with APIs, regulatory requirements, and manufacturing processes. With the growing demand for innovative drug delivery systems, there is an increasing emphasis on the development of novel excipients with improved functionality and performance characteristics.
Global Excipients Market, Segmentation by Function
The Global Excipients Market has been segmented by Function into Binders and Coating Agents.
This division reflects the diverse roles excipients play in pharmaceuticals, food, and other industries. Binders are crucial components in pharmaceutical formulations, aiding in the cohesion of ingredients and ensuring proper tablet compression.
They provide structural integrity to tablets, facilitating their manufacturing process and enhancing their stability. Coating agents, on the other hand, serve multiple purposes, including protecting the active pharmaceutical ingredient (API) from external factors such as moisture and light, improving swallowability, masking taste, and providing aesthetic appeal. These two categories represent fundamental functions within the broader spectrum of excipients, catering to the specific needs of different products and formulations. The dynamic growth of the excipients market underscores the importance of these functional segments, reflecting the continuous innovation and adaptation to evolving industry requirements. As demand for pharmaceuticals and related products continues to rise globally, the significance of excipients in ensuring product efficacy, safety, and quality remains paramount.
Global Excipients Market, Segmentation by Geography
In this report, the Global Excipients Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Global Excipients Market Share (%), by Geographical Region, 2024
North America stands as one of the prominent regions in the global excipients market, owing to the presence of a well-established pharmaceutical industry coupled with significant investments in research and development activities. Moreover, the region's stringent regulatory framework regarding the quality and safety of pharmaceutical products further drives the demand for high-quality excipients.
Europe also holds a substantial share in the global excipients market, fueled by the presence of leading pharmaceutical companies and a growing emphasis on innovative drug formulations. Regulatory initiatives aimed at promoting the use of excipients with minimal risk profiles contribute to the market growth in this region.
The Asia Pacific region is witnessing rapid growth in the excipients market, propelled by increasing healthcare expenditure, expanding pharmaceutical manufacturing capabilities, and a rising demand for generic drugs. Additionally, government initiatives aimed at improving healthcare infrastructure and accessibility further boost the demand for excipients in the region.
The Middle East and Africa region represent emerging markets for excipients, driven by a growing prevalence of chronic diseases, rising healthcare awareness, and investments in pharmaceutical manufacturing facilities. However, challenges such as inadequate healthcare infrastructure and regulatory complexities may impede market growth to some extent.
Latin America also presents significant opportunities for the excipients market, supported by a growing pharmaceutical industry, increasing investments in healthcare infrastructure, and a rising demand for novel drug formulations. Regulatory reforms aimed at streamlining the drug approval process and ensuring product quality are expected to further drive market growth in the region.
Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Global Excipients Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Drivers, Restraints and Opportunities Analysis
Drivers:
- Increasing Pharmaceutical Manufacturing
- Advancements in Drug Delivery Technologies
-
Growing Biopharmaceutical Sector - Excipients, often referred to as inert substances, play a crucial role in pharmaceutical formulations by facilitating drug delivery, improving stability, enhancing solubility, and ensuring consistency in dosage forms. With the burgeoning demand for innovative drug formulations and delivery systems, the biopharmaceutical sector has emerged as a major driver for the excipients market.
One of the key factors driving the growth of the biopharmaceutical sector is the increasing prevalence of chronic diseases, coupled with aging populations worldwide. This demographic shift has led to a growing demand for advanced therapeutics, including biologics and biosimilars, which require specialized excipients for formulation. The rise in personalized medicine and targeted drug delivery approaches has further accentuated the need for excipients tailored to specific drug formulations and patient requirements.
Stringent regulatory guidelines governing pharmaceutical manufacturing and quality standards have underscored the importance of using high-quality excipients in drug formulations. Manufacturers are increasingly focusing on sourcing excipients from reputable suppliers that adhere to stringent quality control measures and regulatory requirements.
The growing emphasis on improving patient compliance and enhancing the therapeutic efficacy of drugs has also spurred innovation in excipient development. Excipients with multifunctional properties, such as taste-masking agents, controlled-release matrices, and mucoadhesive polymers, are being increasingly utilized to optimize drug formulations and improve patient outcomes.
Restraints:
- Limited Availability of Raw Materials
- Price Volatility
-
Quality Control Challenges - Quality control challenges in the global excipients market pose significant restraints on the industry's growth trajectory. These challenges stem from various factors including the complexity of excipient materials, evolving regulatory standards, and the need for stringent quality assurance protocols.
One major hurdle is the diverse nature of excipients themselves. Excipients encompass a wide range of substances that are added to pharmaceutical formulations to impart specific properties such as viscosity, stability, or taste masking. The sheer variety of excipients used in different drug formulations complicates quality control efforts as each substance may require unique testing methodologies and parameters.
As regulatory standards continue to evolve, pharmaceutical companies are under increasing pressure to ensure compliance with strict quality control guidelines. This includes adhering to Good Manufacturing Practices (GMP) and other regulatory requirements set forth by organizations such as the FDA and EMA. Failure to meet these standards can result in costly delays in product approval or even regulatory sanctions.
Another challenge lies in the inherent variability of excipient materials. Natural excipients sourced from plant or animal origins, for example, can exhibit inherent variability due to factors such as climate, soil conditions, or genetic differences. Ensuring consistent quality across batches of natural excipients requires robust quality control measures and rigorous testing protocols.
Opportunities:
- Growing Pharmaceutical Industry
- Rising Demand for Oral Solid Dosage Forms
-
Advancements in Drug Delivery Technologies - The Global Excipients Market is experiencing a significant surge driven by advancements in drug delivery technologies. These advancements present a plethora of opportunities for excipient manufacturers and suppliers. With the continuous evolution of pharmaceutical formulations and drug delivery systems, excipients play a crucial role in enhancing the efficacy, stability, and bioavailability of active pharmaceutical ingredients (APIs).
One notable opportunity lies in the development of novel excipients tailored to meet the specific requirements of advanced drug delivery systems. These systems encompass a wide range of technologies such as nanoparticles, liposomes, micelles, and polymeric drug carriers. Excipients compatible with these delivery systems can enable targeted drug delivery, controlled release, improved solubility, and enhanced bioavailability of drugs.
The growing emphasis on patient-centric drug delivery approaches, such as oral thin films, transdermal patches, and inhalation therapies, opens up avenues for excipient innovation. Excipients that facilitate the formulation of patient-friendly dosage forms, offering improved convenience, compliance, and comfort, are poised to gain traction in the market.
The increasing demand for biopharmaceuticals and complex formulations presents an opportunity for excipient manufacturers to develop specialized excipients suitable for biologics, peptides, and nucleic acid-based therapeutics. These excipients need to address the unique challenges associated with the formulation and delivery of biopharmaceuticals, including stability, immunogenicity, and compatibility with sensitive biomolecules.
Competitive Landscape Analysis
Key players in Global Excipients Market include:
- Eastman Chemical Corporation
- P&G Chemicals
- Avantor Performance Materials, LLC
- Huntsman Corporation
- BASF SE
- Ashland Inc.
- FMC Corporation
- Roquette
- Colorcon Inc.
- Lubrizol Corporation
- Valeant
- JRS Pharma
- Shin-Etsu Chemical Co., Ltd.
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Product
- Market Snapshot, By Function
- Market Snapshot, By Region
- Global Excipients Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
-
Increasing Pharmaceutical Manufacturing
-
Advancements in Drug Delivery Technologies
-
Growing Biopharmaceutical Sector
-
- Restraints
-
Limited Availability of Raw Materials
-
Price Volatility
-
Quality Control Challenges
-
- Opportunities
-
Growing Pharmaceutical Industry
-
Rising Demand for Oral Solid Dosage Forms
-
Advancements in Drug Delivery Technologies
-
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Global Excipients Market, By Product, 2021 - 2031 (USD Million)
-
Polymers
-
Alcohols
-
Sugars
-
Minerals
-
Gelatin
-
- Global Excipients Market, By Function, 2021 - 2031 (USD Million)
-
Binders
-
Coating Agents
-
- Global Excipients Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Global Excipients Market, By Product, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- Eastman Chemical Corporation
- P&G Chemicals
- Avantor Performance Materials, LLC
- Huntsman Corporation
- BASF SE
- Ashland Inc.
- FMC Corporation
- Roquette
- Colorcon Inc.
- Lubrizol Corporation
- Valeant
- JRS Pharma
- Shin-Etsu Chemical Co., Ltd.
- Company Profiles
- Analyst Views
- Future Outlook of the Market